A recent study by Barcelò et al. identified the upregulation of three miRNAs (miR-142-3p, miR-142-5p and miR-223-3p), combined with the serum level of prostate-specific antigen (PSA), in PCa patients compared to healthy controls. The gene discussed is KLK3; the disease is posterior cortical atrophy.